Handel Qiagen NV - QIA CFD
Føj til favorit- Opsummering
- Historisk Data
- Begivenheder
- Resultatopgørelse
- Saldo
- Cash flow
- Ejerskab
Spænd | 0.140 | ||||||||
Long position, gebyr natten over
Long position overnight fee
Gå til platform | -0.019277% | ||||||||
Short position, gebyr natten over
Short position overnight fee
Gå til platform | -0.002946% | ||||||||
Gebyr natten over, tid | 21:00 (UTC) | ||||||||
Min. handlet mængde | 1 | ||||||||
Valuta | EUR | ||||||||
Margen | 20% | ||||||||
Aktiebørs | Germany | ||||||||
Kommission på handel | 0% |
*Information provided by Capital.com
Qiagen NV ESG Risk Ratings
‘B’ score indicates good relative ESG performance and above average degree of transparency in reporting material ESG data publicly.
Tidligere luk* | 42.25 |
Åben* | 42.3 |
1-Års Ændring* | -5.41% |
Dagens Spænd* | 41.76 - 42.3 |
52-Ugers Spænd | 40.38-51.18 |
Gennemsnitlig Volumen (10 dage) | 654.15K |
Gennemsnitlig Volumen (3 måneder) | 13.68M |
Market Cap | 10.42B |
P/E-forhold | 24.87 |
Udestående aktier | 227.72M |
Omsætning | 2.14B |
EPS | 1.84 |
Dividend (Udbytte %) | N/A |
Beta | 0.39 |
Næste indtjeningsopgørelse | Apr 24, 2023 |
Al data kommer fra Refinitiv, med undtagelse af data markeret med en asterisk, som er *data fra Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Luk | Change | Change (%) | Åben | High | Low |
---|---|---|---|---|---|---|
Mar 29, 2023 | 42.250 | 0.300 | 0.72% | 41.950 | 42.430 | 41.880 |
Mar 28, 2023 | 42.140 | -0.720 | -1.68% | 42.860 | 43.090 | 42.090 |
Mar 27, 2023 | 42.920 | 0.060 | 0.14% | 42.860 | 43.130 | 42.690 |
Mar 24, 2023 | 42.390 | 0.200 | 0.47% | 42.190 | 43.050 | 42.190 |
Mar 23, 2023 | 42.540 | 0.290 | 0.69% | 42.250 | 42.560 | 42.010 |
Mar 22, 2023 | 42.760 | 0.100 | 0.23% | 42.660 | 43.060 | 42.660 |
Mar 21, 2023 | 42.680 | 0.090 | 0.21% | 42.590 | 42.850 | 42.390 |
Mar 20, 2023 | 42.630 | -0.420 | -0.98% | 43.050 | 43.330 | 42.550 |
Mar 17, 2023 | 43.180 | 0.080 | 0.19% | 43.100 | 44.000 | 43.080 |
Mar 16, 2023 | 43.720 | -0.030 | -0.07% | 43.750 | 43.890 | 43.180 |
Mar 15, 2023 | 43.190 | 0.250 | 0.58% | 42.940 | 43.440 | 42.420 |
Mar 14, 2023 | 42.960 | -0.400 | -0.92% | 43.360 | 43.580 | 42.180 |
Mar 13, 2023 | 43.240 | 0.060 | 0.14% | 43.180 | 43.680 | 43.180 |
Mar 10, 2023 | 43.500 | 0.280 | 0.65% | 43.220 | 43.930 | 43.220 |
Mar 9, 2023 | 43.710 | 0.490 | 1.13% | 43.220 | 43.800 | 43.210 |
Mar 8, 2023 | 43.620 | 0.260 | 0.60% | 43.360 | 43.710 | 43.280 |
Mar 7, 2023 | 43.790 | -0.060 | -0.14% | 43.850 | 44.260 | 43.700 |
Mar 6, 2023 | 43.570 | 0.240 | 0.55% | 43.330 | 43.790 | 43.210 |
Mar 3, 2023 | 43.420 | 0.230 | 0.53% | 43.190 | 43.500 | 43.070 |
Mar 2, 2023 | 42.890 | 0.320 | 0.75% | 42.570 | 43.030 | 42.360 |
Qiagen NV Events
Tid (UTC) (UTC) | Land | Begivenhed |
---|---|---|
No events scheduled |
- Årlig
- Pr kvartal
2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|
Total omsætning | 2141.52 | 2251.66 | 1870.35 | 1526.42 | 1501.85 |
Omsætning | 2141.52 | 2251.66 | 1870.35 | 1526.42 | 1501.85 |
Kost af omsætning, Total | 756.955 | 800.837 | 637.631 | 521.162 | 499.271 |
Bruttofortjeneste | 1384.56 | 1450.82 | 1232.71 | 1005.26 | 1002.58 |
Totale Driftsudgifter | 1610.06 | 1621.57 | 1483.92 | 1547.76 | 1235.27 |
Salgs/Generelle/Admin. Udgifter, Total | 603.945 | 584.468 | 525.362 | 505.268 | 508.146 |
Forskning & Udvikling | 189.859 | 189.964 | 149.072 | 157.448 | 161.852 |
Depreciation / Amortization | 14.531 | 18.542 | 20.811 | 29.973 | 39.032 |
Usædvanlig Udgift (Indkomst) | 44.768 | 27.762 | 151.039 | 333.91 | 26.966 |
Driftsindtægter | 531.46 | 630.084 | 386.431 | -21.337 | 266.581 |
Renteindkomst (Udgift), Netto Ikke-Drift | -19.1 | -5.122 | -59.918 | -43.696 | -70.168 |
Andre, Netto | 0.241 | 0.871 | 112.959 | -12.743 | 29.324 |
Netto Indkomst Før Skat | 512.601 | 625.833 | 439.472 | -77.776 | 225.737 |
Netto Indkomst Efter Skat | 423.211 | 512.599 | 359.188 | -41.455 | 190.38 |
Minoritetsrente | 0 | ||||
Netto Indkomst Før Ekstra Ting | 423.211 | 512.599 | 359.188 | -41.455 | 190.38 |
Netto Indkomst | 423.211 | 512.599 | 359.188 | -41.455 | 190.38 |
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | 423.211 | 512.599 | 359.188 | -41.455 | 190.38 |
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | 423.211 | 512.599 | 359.188 | -41.455 | 190.38 |
Fortyndelsesændring | 0 | ||||
Fortyndet Netto Indkomst | 423.211 | 512.599 | 359.188 | -41.455 | 190.38 |
Fortyndet Vægtet Gennemsnit Aktier | 230.136 | 232.034 | 234.214 | 226.777 | 233.456 |
Fortyndet EPS Uden Ekstraordinære Ting | 1.83896 | 2.20915 | 1.53359 | -0.1828 | 0.81549 |
Fortyndet Normaliseret EPS | 1.99957 | 2.30715 | 2.00343 | 0.77427 | 0.9129 |
Totale Ekstraordinære Ting |
Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 | Dec 2021 | |
---|---|---|---|---|---|
Total omsætning | 497.984 | 499.631 | 515.512 | 628.391 | 582.398 |
Omsætning | 497.984 | 499.631 | 515.512 | 628.391 | 582.398 |
Kost af omsætning, Total | 180.46 | 178.58 | 184.494 | 213.421 | 208.574 |
Bruttofortjeneste | 317.524 | 321.051 | 331.018 | 414.97 | 373.824 |
Totale Driftsudgifter | 393.411 | 401.972 | 393.355 | 421.32 | 409.257 |
Salgs/Generelle/Admin. Udgifter, Total | 154.211 | 145.462 | 151.418 | 152.854 | 152.274 |
Forskning & Udvikling | 44.719 | 48.868 | 49.896 | 46.376 | 42.113 |
Depreciation / Amortization | 5.969 | 2.846 | 2.799 | 2.917 | 3.345 |
Usædvanlig Udgift (Indkomst) | 8.052 | 26.216 | 4.748 | 5.752 | 2.951 |
Driftsindtægter | 104.573 | 97.659 | 122.157 | 207.071 | 173.141 |
Renteindkomst (Udgift), Netto Ikke-Drift | 1.387 | -2.452 | -6.521 | -11.414 | -7.275 |
Andre, Netto | -0.123 | 0.511 | -0.112 | -0.135 | -0.487 |
Netto Indkomst Før Skat | 105.837 | 95.718 | 115.524 | 195.522 | 165.379 |
Netto Indkomst Efter Skat | 88.844 | 82.394 | 96.661 | 155.312 | 129.186 |
Netto Indkomst Før Ekstra Ting | 88.844 | 82.394 | 96.661 | 155.312 | 129.186 |
Netto Indkomst | 88.844 | 82.394 | 96.661 | 155.312 | 129.186 |
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | 88.844 | 82.394 | 96.661 | 155.312 | 129.186 |
Indkomst Tilgængelig for Almindelige Uden Ekstra Ting | 88.844 | 82.394 | 96.661 | 155.312 | 129.186 |
Fortyndet Netto Indkomst | 88.844 | 82.394 | 96.661 | 155.312 | 129.186 |
Fortyndet Vægtet Gennemsnit Aktier | 230.358 | 230.084 | 229.938 | 230.164 | 231.761 |
Fortyndet EPS Uden Ekstraordinære Ting | 0.38568 | 0.3581 | 0.42038 | 0.67479 | 0.55741 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | ||
Fortyndet Normaliseret EPS | 0.41502 | 0.45618 | 0.43766 | 0.69464 | 0.56736 |
- Årlig
- Pr kvartal
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Totale Nuværende Aktiver | 2109.6 | 1624.41 | 1570.25 | 2155.06 | 1647.97 |
Likvider og Kortsigtede Investeringer | 1065.3 | 715.233 | 753.233 | 1393.69 | 657.714 |
Cash | 235.381 | 245.373 | 189.569 | 208.083 | 139.597 |
Kortsigtede Investeringer | 184.785 | 117.249 | 563.664 | 1185.6 | 518.117 |
Totale Tilgodehavender, Netto | 469.663 | 486.605 | 484.608 | 422.091 | 761.617 |
Accounts Receivable - Trade, Net | 376.213 | 389.058 | 385.117 | 351.612 | 329.138 |
Total Inventory | 327.525 | 291.181 | 170.704 | 162.912 | 155.927 |
Prepaid Expenses | 60.629 | 61.159 | 45.409 | 48.25 | 41.775 |
Other Current Assets, Total | 186.484 | 70.227 | 116.294 | 128.122 | 30.94 |
Total Assets | 6146.95 | 5869.62 | 5235.62 | 5748.33 | 5038.52 |
Property/Plant/Equipment, Total - Net | 739.077 | 661.894 | 455.243 | 511.659 | 494.321 |
Property/Plant/Equipment, Total - Gross | 1371.49 | 1292.34 | 1154.37 | 1115.09 | 1058.91 |
Accumulated Depreciation, Total | -632.416 | -630.443 | -699.13 | -603.43 | -564.588 |
Goodwill, Net | 2350.76 | 2364.03 | 2140.5 | 2108.54 | 2012.9 |
Intangibles, Net | 627.436 | 726.194 | 632.434 | 475.043 | 499.318 |
Other Long Term Assets, Total | 294.676 | 488.995 | 356.488 | 437.434 | 328.7 |
Total Current Liabilities | 1517.47 | 572.175 | 951.345 | 972.189 | 324.792 |
Accounts Payable | 101.224 | 118.153 | 84.767 | 69.415 | 59.205 |
Accrued Expenses | 219.936 | 220.755 | 332.151 | 209.748 | 173.307 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 847.626 | 42.539 | 285.244 | 503.177 | 1.359 |
Other Current Liabilities, Total | 348.684 | 190.728 | 249.183 | 189.849 | 90.921 |
Total Liabilities | 3050.4 | 3071.78 | 2699.02 | 3113.36 | 2497.52 |
Total Long Term Debt | 1094.14 | 1880.21 | 1421.11 | 1671.09 | 1758.26 |
Long Term Debt | 1094.14 | 1880.21 | 1421.11 | 1671.09 | 1758.26 |
Deferred Income Tax | 37.591 | 39.216 | 23.442 | 63.411 | 76.727 |
Minority Interest | |||||
Other Liabilities, Total | 401.199 | 580.179 | 303.13 | 406.672 | 337.743 |
Total Equity | 3096.55 | 2797.84 | 2536.59 | 2634.97 | 2541 |
Common Stock | 2.702 | 2.702 | 2.702 | 2.702 | 2.702 |
Additional Paid-In Capital | 1818.51 | 1834.17 | 1777.02 | 1742.19 | 1630.09 |
Retained Earnings (Accumulated Deficit) | 1791.74 | 1323.09 | 1178.46 | 1379.62 | 1247.94 |
Treasury Stock - Common | -189.73 | -118.301 | -111.966 | -178.903 | -118.987 |
Unrealized Gain (Loss) | 0 | -0.942 | |||
Other Equity, Total | -326.67 | -243.822 | -309.619 | -310.644 | -219.817 |
Total Liabilities & Shareholders’ Equity | 6146.95 | 5869.62 | 5235.62 | 5748.33 | 5038.52 |
Total Common Shares Outstanding | 227.074 | 227.985 | 227.752 | 225.509 | 226.557 |
Long Term Investments | 25.4 | 4.1 | 80.7 | 60.6 | 41.1 |
Note Receivable - Long Term | 14.2 | ||||
Likvider & Lignende | 645.135 | 352.611 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Totale Nuværende Aktiver | 2097.25 | 2109.6 | 2028.4 | 1802.19 | 1665.55 |
Likvider og Kortsigtede Investeringer | 1229.8 | 1065.3 | 957.318 | 898.021 | 791.732 |
Likvider & Lignende | 770.515 | 880.516 | 617.541 | 759.047 | 787.786 |
Kortsigtede Investeringer | 459.285 | 184.785 | 339.777 | 138.974 | 3.946 |
Totale Tilgodehavender, Netto | 386.683 | 376.213 | 373.62 | 366.151 | 371.694 |
Accounts Receivable - Trade, Net | 386.683 | 376.213 | 372.22 | 366.151 | 371.694 |
Total Inventory | 321.621 | 327.525 | 335.691 | 341.041 | 316.28 |
Prepaid Expenses | 159.147 | 165.279 | 361.767 | 196.982 | 185.844 |
Total Assets | 6184.28 | 6146.95 | 6043.43 | 5907.48 | 5762.61 |
Property/Plant/Equipment, Total - Net | 638.225 | 739.077 | 612.114 | 599.991 | 563.917 |
Property/Plant/Equipment, Total - Gross | 1244.08 | 1270.6 | 1245.82 | 1245.04 | 1186.38 |
Accumulated Depreciation, Total | -605.858 | -632.416 | -633.706 | -645.05 | -622.464 |
Goodwill, Net | 2346.74 | 2350.76 | 2353.91 | 2332.7 | 2335.27 |
Intangibles, Net | 607.738 | 627.436 | 638.786 | 667.273 | 695.937 |
Long Term Investments | 26.6 | 25.4 | 19.5 | 21.5 | 17.1 |
Other Long Term Assets, Total | 467.728 | 294.676 | 390.72 | 483.821 | 484.836 |
Total Current Liabilities | 957.283 | 1517.47 | 1070.03 | 503.117 | 499.384 |
Accounts Payable | 87.012 | 101.224 | 94.265 | 103.004 | 103.471 |
Accrued Expenses | 335.279 | 568.62 | 571.229 | 325.813 | 335.713 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Port. of LT Debt/Capital Leases | 468.792 | 847.626 | 371.637 | 0 | 0 |
Other Current Liabilities, Total | 66.2 | 32.9 | 74.3 | 60.2 | |
Total Liabilities | 2944.14 | 3050.4 | 3029.69 | 2929.6 | 2912.83 |
Total Long Term Debt | 1474.9 | 1094.14 | 1568.66 | 1939.71 | 1928.95 |
Long Term Debt | 1474.9 | 1094.14 | 1568.66 | 1939.71 | 1928.95 |
Deferred Income Tax | 36.921 | 37.591 | 22.102 | 22.824 | 10.146 |
Other Liabilities, Total | 475.038 | 401.199 | 368.9 | 463.951 | 474.353 |
Total Equity | 3240.14 | 3096.55 | 3013.74 | 2977.87 | 2849.78 |
Common Stock | 2.702 | 2.702 | 2.702 | 2.702 | 2.702 |
Additional Paid-In Capital | 1830.59 | 1818.51 | 1811.54 | 1799.41 | 1789.81 |
Retained Earnings (Accumulated Deficit) | 1913.66 | 1791.74 | 1665.67 | 1537.48 | 1430.53 |
Treasury Stock - Common | -172.993 | -189.73 | -174.565 | -100.763 | -107.014 |
Other Equity, Total | -333.822 | -326.67 | -291.601 | -260.966 | -266.245 |
Total Liabilities & Shareholders’ Equity | 6184.28 | 6146.95 | 6043.43 | 5907.48 | 5762.61 |
Total Common Shares Outstanding | 227.452 | 227.074 | 227.336 | 228.638 | 228.407 |
Other Current Assets, Total | 175.284 |
- Årlig
- Pr kvartal
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Netto indkomst/Startlinje | 512.599 | 359.188 | -41.455 | 190.38 | 40.394 |
Likvider Fra Driftsaktiviteter | 639.001 | 457.806 | 330.843 | 359.496 | 286.779 |
Likvider Fra Driftsaktiviteter | 214.931 | 205.014 | 231.458 | 206.436 | 216.448 |
Deferred Taxes | -5.288 | -6.706 | -55.362 | -23.272 | 60.176 |
Ikke-Likvide Ting | 46.771 | -27.423 | 240.526 | 81.111 | 57.617 |
Cash Taxes Paid | 102.083 | 42.572 | 41.474 | 29.317 | 40.499 |
Likvid Rente Betalt | 21.588 | 25.351 | 29.721 | 25.902 | 20.252 |
Ændringer i Driftskapital | -130.012 | -72.267 | -44.324 | -95.159 | -87.856 |
Likvider fra Investeringsaktiviteter | -202.426 | -443.281 | -222.278 | -211.356 | -464.264 |
Kapitaludgifter | -206.534 | -304.237 | -274.884 | -150.763 | -124.405 |
Andre Investerings-Cash-Flow-Ting, Total | 4.108 | -139.044 | 52.606 | -60.593 | -339.859 |
Likvider fra Financieringsaktiviteter | -150.366 | -50.127 | -639.08 | 360.408 | 387.187 |
Financiering af Cash-Flow-Ting | -16.953 | -23.451 | -61.279 | -8.019 | -8.587 |
Udstedelse (Pensionering) af Aktier, Netto | -92.068 | 8.876 | 62.362 | -27.867 | -253.444 |
Udstedelse (Pensionering) af Gæld, Netto | -41.345 | -35.552 | -640.163 | 396.294 | 649.218 |
Udenlandsk Børs Effekter | -3.677 | 4.196 | 0.826 | -7.183 | 8.832 |
Netto Ændring i Likviditet | 282.532 | -31.406 | -529.689 | 501.365 | 218.534 |
Mar 2022 | Dec 2021 | Sep 2021 | Jun 2021 | Mar 2021 | |
---|---|---|---|---|---|
Net income/Starting Line | 155.312 | 512.599 | 383.413 | 250.274 | 129.223 |
Cash From Operating Activities | 207.41 | 639.001 | 440.543 | 285.026 | 128.627 |
Cash From Operating Activities | 52.998 | 214.931 | 163.83 | 110.669 | 55.587 |
Deferred Taxes | 0.615 | -5.288 | -29.394 | -30.993 | -28.396 |
Non-Cash Items | 21.86 | 46.771 | 35.251 | 40.196 | 12.034 |
Changes in Working Capital | -23.375 | -130.012 | -112.557 | -85.12 | -39.821 |
Cash From Investing Activities | -306.252 | -202.426 | -297.717 | -78.682 | 105.975 |
Capital Expenditures | -38.415 | -206.534 | -152.531 | -101.254 | -54.959 |
Other Investing Cash Flow Items, Total | -267.837 | 4.108 | -145.186 | 22.572 | 160.934 |
Cash From Financing Activities | -10.658 | -150.366 | -119.397 | -43.478 | -40.852 |
Financing Cash Flow Items | -10.687 | -16.953 | -3.625 | -4.847 | -2.017 |
Issuance (Retirement) of Stock, Net | 0.029 | -92.068 | -74.427 | 2.714 | 2.51 |
Issuance (Retirement) of Debt, Net | 0 | -41.345 | -41.345 | -41.345 | -41.345 |
Foreign Exchange Effects | -0.501 | -3.677 | -3.872 | -1.803 | -3.948 |
Net Change in Cash | -110.001 | 282.532 | 19.557 | 161.063 | 189.802 |
Investornavn | Investortype | Procent udestående | Aktiebeholdning | Aktieændring | Beholdningsdato | IOmsætningsscore |
---|---|---|---|---|---|---|
MFS Investment Management | Investment Advisor/Hedge Fund | 8.6971 | 19804737 | 392074 | 2022-12-31 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 3.6439 | 8297775 | 129513 | 2022-12-31 | LOW |
Norges Bank Investment Management (NBIM) | Sovereign Wealth Fund | 2.5214 | 5741604 | 932553 | 2022-12-31 | LOW |
Amundi Asset Management, SAS | Investment Advisor/Hedge Fund | 2.4157 | 5500907 | 100754 | 2022-12-31 | HIGH |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 1.9693 | 4484423 | 201234 | 2022-12-31 | LOW |
J O Hambro Capital Management Limited | Investment Advisor/Hedge Fund | 1.8894 | 4302433 | -955906 | 2022-12-31 | MED |
UBS Asset Management (Switzerland) | Investment Advisor | 1.8793 | 4279398 | 765282 | 2022-12-19 | LOW |
Arrowstreet Capital, Limited Partnership | Investment Advisor/Hedge Fund | 1.625 | 3700311 | 215475 | 2022-12-31 | MED |
Capital World Investors | Investment Advisor | 1.6138 | 3674825 | 0 | 2022-12-31 | LOW |
BlackRock Asset Management Deutschland AG | Investment Advisor | 1.3725 | 3125386 | 101378 | 2023-02-28 | LOW |
Schroder Investment Management Ltd. (SIM) | Investment Advisor/Hedge Fund | 1.3706 | 3120999 | 0 | 2023-01-31 | LOW |
Acadian Asset Management LLC | Investment Advisor/Hedge Fund | 1.1858 | 2700209 | -568539 | 2022-12-31 | MED |
Wellington Management Company, LLP | Investment Advisor/Hedge Fund | 1.141 | 2598279 | -510278 | 2022-12-31 | LOW |
Fidelity International | Investment Advisor | 0.9847 | 2242311 | 85153 | 2022-12-31 | LOW |
Marshall Wace LLP | Investment Advisor/Hedge Fund | 0.9721 | 2213542 | -138096 | 2022-12-31 | HIGH |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 0.9392 | 2138763 | -104054 | 2022-12-31 | LOW |
BofA Global Research (US) | Research Firm | 0.9294 | 2116389 | -914109 | 2022-12-31 | LOW |
Legal & General Investment Management Ltd. | Investment Advisor/Hedge Fund | 0.9046 | 2060006 | 265911 | 2022-12-31 | LOW |
Davidson Kempner Capital Management LP | Hedge Fund | 0.8948 | 2037709 | -61957 | 2022-12-31 | HIGH |
Morgan Stanley & Co. LLC | Research Firm | 0.8507 | 1937191 | 116735 | 2022-12-31 | MED |
Hvorfor vælge Capital.com? Vores tal taler for sig selv.
Capital.com Group500K+
Handlende
92K+
Månedlkige, aktive klienter
$53M+
Månedlig investeringsvolumen
$30M+
Hævet hver måned
Handelslommeregner
Udregn dit hypotetiske P&L hvis du havde åbnet en CFD-handel på en given dato (vælg en dato) og lukket den på en anden dato (vælg en dato).
- 1:1
- 20
- 100
- 500
- 1000
- 10000
Qiagen Company profile
Om Qiagen NV
Qiagen NV er et holdingselskab med hovedsæde i Nederlandene. Selskabet beskæftiger sig med at levere løsninger fra prøve til indsigt, der omdanner biologiske prøver til molekylær indsigt. Dens Sample to Insight-løsninger integrerer prøve- og assayteknologier, bioinformatik og automatiseringssystemer. Virksomhedens prøveteknologier anvendes til at isolere og forberede desoxyribonukleinsyre (DNA), ribonukleinsyre (RNA) og proteiner fra blod eller andre væsker, væv, planter eller andre materialer. Dets analyseteknologier gør disse biomolekyler synlige med henblik på analyse, f.eks. til identifikation af genetiske oplysninger om et patogen eller en genmutation i en tumor. Dets bioinformatikløsninger fortolker data for at give indsigt, der kan bruges til handling. Selskabets automatiseringsplatforme baseret på polymerasekædereaktion (PCR), næste generations sekventering (NGS) og andre teknologier binder disse sammen i molekylære testarbejdsgange fra prøve til indsigt.
Industry: | Biotechnology & Medical Research (NEC) |
Hulsterweg 82
VENLO
LIMBURG 5912 PL
NL
Resultatopgørelse
- Annual
- Quarterly
Folk ser også
Leder du stadig efter en mægler, du kan stole på?
Deltag sammen med 500.000+ handlende over hele verden, der valgte at handle hos Capital.com